Blueshift Asset Management’s Bristol-Myers Squibb BMY Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-5,345	Closed	-$222K	–	365
2024 Q2	$222K	Buy	+5,345	New	+$239K	0.07%	304
2024 Q1	–	Sell	-4,214	Closed	-$216K	–	278
2023 Q4	$216K	Buy	+4,214	New	+$221K	0.11%	227
2023 Q3	–	Sell	-3,428	Closed	-$219K	–	288
2023 Q2	$219K	Sell	3,428 -2,726	-44%	-$183K	0.08%	284
2023 Q1	$427K	Buy	6,154 +177	+3%	+$12.5K	0.18%	159
2022 Q4	$430K	Buy	+5,977	New	+$451K	0.2%	147
2022 Q2	–	Sell	-27,124	Closed	-$1.98M	–	702
2022 Q1	$1.98M	Buy	+27,124	New	+$1.82M	0.18%	147
2021 Q4	–	Sell	-249,521	Closed	-$14.8M	–	870
2021 Q3	$14.8M	Buy	249,521 +227,131	+1,014%	+$15M	0.83%	6
2021 Q2	$1.5M	Buy	22,390 +131	+0.6%	+$8.54K	0.08%	269
2021 Q1	$1.41M	Buy	+22,259	New	+$1.38M	0.14%	192
2020 Q1	–	Sell	-52,025	Closed	-$3.34M	–	237
2019 Q4	$3.34M	Buy	+52,025	New	+$2.98M	0.38%	48